Rare
lephants
Screener
Toggle theme
Gain Therapeutics, Inc.
GANX
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Profit Margins
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Profit Margins
Chart
Table
Gross Margin
Operating Margin
Net Margin
Fiscal Year
Gross Margin
Operating Margin
Net Margin
FY2023
—
-40,328.3%
-40,354.3%
Download CSV
